Pulse - Value AddedPULSEValue Added
← Library
Knowledge Library · Tools
Powered by Pulse — Value Added. The #1 source of truth in revenue operations. Find the bottleneck. Fix the pipeline. Win the quarter.

How do I run a win-loss analysis to diagnose why deals are stalling before I bring in a fractional CRO in 2027?

Curated by · Fractional CRO · Maryland
pulserevops.com
✓
Quality
Certified
Pulse ToolsHow do I run a win-loss analysis to diagnose why deals are stalling before I bring in a fractional CRO in 2027?
Rent this Advertising Space
📖 2,374 words🗓️ Published Sep 23, 2026
Direct Answer

Run a win-loss analysis by pulling 15-20 recently closed-won, closed-lost, and stalling deals, interviewing the actual buyer — not just your rep's notes — within two weeks of the outcome, then scoring every answer against a fixed rubric (fit, price, timing, competitor, internal champion). Pattern-match the results before a fractional CRO starts, so a documented diagnosis, not a guess, sets their first 90 days.

This vs. the common alternatives

Most companies "diagnose" a stalling pipeline with whatever data is already sitting in the CRM: stage-duration reports, win-rate dashboards, and a rep's closed-lost reason code picked from a dropdown. That data tells you *where* deals die, not *why*. A stage report shows a deal sat in "Proposal Sent" for 61 days; it cannot tell you the buyer went dark because procurement flagged a security gap, because a champion left the company, or because your price came in 30% over a budget nobody disclosed until the third call. Dropdown reason codes are worse — reps mark almost everything "no budget" or "went with a competitor" because those are the two options that require the least reflection, and neither is actionable.

The second common alternative is the internal post-mortem: sales and marketing sit in a room and debate why a deal fell apart based on memory and the rep's version of events. This is faster than a real win-loss analysis and costs nothing extra, but it is structurally biased — the rep who lost the deal is grading their own performance, and nobody in the room actually talked to the buyer after the deal died. Teams using only internal post-mortems consistently overweight price and competitor strength as loss causes and underweight internal execution problems (slow follow-up, unclear next steps, the wrong stakeholder pitched), because those are harder for the team to say out loud about itself.

How do I run a win-loss analysis to diagnose why deals are stalling before I bring in a fractional CRO in 2027 — figure 1

A third alternative, popular with founders under time pressure, is skipping diagnosis entirely and hiring a fractional CRO to "figure it out." This inverts the order that actually works. A fractional operator engaged two or three days a week burns their most expensive hours re-discovering what a structured analysis could have surfaced in two weeks — and they discover it secondhand, through your team's account of events, which carries the same bias problem as the internal post-mortem. The strongest version of the engagement flips this: the win-loss analysis is complete and written up *before* the CRO's first week, so their scarce hours go straight to fixing the top three causes instead of re-running discovery your own team could have done.

The actual best practice, used by RevOps-mature organizations, is a structured win-loss interview program: a consistent question set, a neutral interviewer (internal RevOps, not the AE who owns the deal), and buyer-side conversations across a stratified sample of wins, losses, and — critically, and often skipped — deals that are still open but have gone quiet. Stalling deals are the most diagnostically valuable category of all, because a closed-lost deal only tells you the ending; a stalling deal lets you intervene while the outcome is still undecided.

How do I run a win-loss analysis to diagnose why deals are stalling before I bring in a fractional CRO in 2027 — figure 2

How to choose between them

The right method depends on two variables: how many deals you have to study, and whether anyone inside your company can interview a buyer without the buyer softening their answer to be polite to the person who sold to them. If your monthly deal volume is under roughly ten opportunities, a rigorous manual process covering every deal is realistic. Above that, stratify a sample — a mix across deal size, segment, and sales stage — rather than trying to interview everyone, since diminishing returns set in once you've heard the same three or four root causes repeat across ten-plus conversations.

The interviewer question matters more than most teams assume. Buyers routinely give a softer, vaguer answer to the rep who sold to them than to a neutral third party, because bluntness feels confrontational one-on-one. If you have no internal RevOps or ops function independent of sales, or if deal sizes are large enough that an honest answer is worth real money, a third-party win-loss interview (a consultant or specialist firm) is worth the added cost specifically to remove that bias — not because your own team can't ask questions, but because the buyer answers a stranger more candidly than they answer the person who just lost their business.

How do I run a win-loss analysis to diagnose why deals are stalling before I bring in a fractional CRO in 2027 — figure 3

Stalling deals need a slightly different question set than closed deals, because the buyer hasn't finished deciding and the goal is different. For closed-won and closed-lost deals, you're reconstructing a decision that already happened. For a stalling deal, you're trying to surface a blocker while there's still time to remove it — a missing stakeholder, an unresolved security review, a champion who quietly changed roles. Treat the stalling-deal interview as diagnostic triage, not a retrospective, and route what you find directly to the rep still working the deal, not just into the aggregate report.

Costs, timelines, and expected impact

A first structured win-loss analysis, covering roughly 15-20 deals across won, lost, and stalling, typically runs two to four weeks end to end: a week to build the interview guide and pull the sample, one to two weeks to schedule and conduct the conversations (buyers are slower to respond than your own team, and some will decline), and a few days to code the findings and write the report. Running it in parallel with your fractional CRO search, rather than sequentially, is usually the better trade — the report is ready roughly when the CRO starts, instead of adding a month of delay in front of the engagement.

How do I run a win-loss analysis to diagnose why deals are stalling before I bring in a fractional CRO in 2027 — figure 4

Cost scales with who does the interviewing. Done internally by an existing RevOps or sales-ops hire, the direct cost is only their time — typically 15-25 hours across the cycle for a 15-20 deal sample. Outsourced to a dedicated win-loss analysis firm, per-interview pricing commonly lands in the low hundreds of dollars per completed conversation, which puts a 15-20 interview program in the low-to-mid four-figure range in total; larger enterprise-motion companies running continuous win-loss programs spend considerably more because they run it every quarter rather than once. Treat any number here as a planning range, not a quote — it moves with sample size, deal complexity, and whether you need a native-language interviewer for a global buyer base.

The expected impact, when done properly, is a ranked list of the three to five actual reasons deals are stalling — not twelve vague possibilities, but the two or three that recur across most of the sample. Common patterns that a rigorous analysis surfaces: the sales process is skipping a required stakeholder (legal, security, or a budget owner) until too late in the cycle; pricing is being introduced without enough value-framing ahead of it; there's a gap between the demo and how the product performs in a proof-of-concept; or the rep team lacks a repeatable way to reconfirm the champion is still internally selling on your behalf between calls. Each of those points to a different fix, and each fix is a different first-90-day priority for whoever you bring in to run revenue — which is exactly why skipping the analysis and hiring first, then diagnosing, wastes the most expensive hours you're paying for.

How do I run a win-loss analysis to diagnose why deals are stalling before I bring in a fractional CRO in 2027 — figure 5

Implementation and handoff details

Start by defining the sample before you touch a calendar. Pull deals from the last two to three sales cycles so the findings reflect your current process, not something you already fixed six months ago. Split the sample deliberately: some closed-won (to learn what's working and shouldn't be broken by a new leader), some closed-lost, and — the piece teams skip — deals open more than 30 days past their expected close date with no forward motion. That last bucket is where "stalling" lives, and it is the group most directly relevant to what a fractional CRO needs to know on day one.

Build a short, consistent interview guide before the first call, and use the same one for every conversation so answers are comparable across the sample. Ask open questions before specific ones: what prompted them to evaluate a solution at all, how they compared options, who else was involved in the decision, what almost stopped the deal at any point, and — for a stalling deal specifically — what would need to happen for them to move forward again. Avoid leading questions that assume you already know the answer ("was it the pricing?"); let the buyer name the blocker themselves.

How do I run a win-loss analysis to diagnose why deals are stalling before I bring in a fractional CRO in 2027 — figure 6

Code every completed interview against the same fixed rubric — the same five or six categories every time (product fit, price, timing, competitor, internal champion strength, process friction) — so you can count frequency instead of relying on impression. A spreadsheet is sufficient; the discipline is in using identical categories across every interview, not the tooling. Once the sample is coded, the write-up should be short: one to two pages naming the top three to five causes, ranked by how often they appeared, with one or two direct buyer quotes per cause as evidence. Hand that brief to the fractional CRO before their first working day, and make it part of the engagement scope document itself — their first 30 days should map directly onto fixing the causes the analysis surfaced, not repeating the discovery work you already paid for.

Related questions

Should I run the win-loss analysis myself or hire someone before the fractional CRO starts?

If you have an internal RevOps or ops person independent of sales, run it internally to save cost and move faster. If deal sizes are large or no independent interviewer exists, a third-party win-loss analysis firm removes the bias of a buyer being polite to the rep who sold to them.

How many stalling deals should I include in the sample?

Include every deal open more than 30 days past its expected close with no forward motion, up to a reasonable cap — for most companies that is 5-10 stalling deals alongside 10-15 closed won/lost, enough to spot repeated patterns without over-investing before the CRO arrives.

What if the fractional CRO wants to run their own win-loss process instead?

Let them refine the format going forward, but the pre-hire analysis still has value — it gives them a documented baseline on day one instead of a blank page, and it's useful evidence for whether their diagnosis agrees with what buyers already told you.

Does a win-loss analysis replace normal pipeline and forecast reviews?

No — it's a one-time or periodic diagnostic, not a replacement for the ongoing cadence (pipeline reviews, forecast calls) a fractional CRO installs. Think of it as the input that tells the CRO which parts of that cadence need fixing first.

FAQ

How soon after a deal closes should I interview the buyer? Within two weeks. Memory degrades fast, and waiting longer means the buyer conflates this decision with others, or forgets the specific moment something almost derailed it.

Can my own sales reps conduct these interviews? It's possible but risky for lost and stalling deals — buyers give softer, more polite answers to the person who sold to them. If reps must do it, have someone else review and code the raw notes rather than trusting the rep's own summary.

What's the minimum sample size that produces a usable diagnosis? Around 10-15 completed interviews is usually enough to see two or three causes repeat. Below that, a single unusual deal can distort the whole picture.

Should the fractional CRO see the raw interview notes or just the summary? Give them both — the ranked summary for speed, and the raw notes as backup so they can verify the analysis themselves and catch any nuance the coding rubric flattened.

Is a win-loss analysis a one-time project or an ongoing program? Do it once as a baseline before the CRO starts, then let them decide whether to make it quarterly. Mature RevOps organizations typically run it continuously because buyer behavior and competitive pressure shift.

What if buyers won't respond to interview requests? Expect a real decline rate — offer a short 15-minute call instead of a long survey, and frame it as product feedback rather than a sales follow-up, which raises response rates noticeably.

Sources

flowchart TD S["How do I run a win-loss analysis to di"] S --> N0["This vs. the common alternatives"] N0 --> N1["How to choose between them"] N1 --> N2["Costs, timelines, and expected impact"] N2 --> N3["Implementation and handoff details"]
flowchart LR C["How do I run a win-loss analysis to di"] C --> H0["This vs. the common alternatives"] C --> H1["How to choose between them"] C --> H2["Costs, timelines, and expected impact"] C --> H3["Implementation and handoff details"]

Related on PULSE

Download:
Was this helpful?  
This page will be disappearing soon.
Download the whole page as a PDF to keep — just $1.
⌬ Apply this in PULSE
Gross Profit CalculatorModel margin per deal, per rep, per territory